Mortality for Any Hepatic Cause in People With Diabetes Compared to the Non‐Diabetic Population. A 10‐Year‐Observational Study

This study highlights the need for targeted interventions to manage hepatic complications in diabetic patients, focusing on glycemic control, liver fibrosis assessment, and alcohol consumption reduction. The possible beneficial effects of incretins and SGLT2 inhibitors, along with the possible adverse impact of insulin, should be interpreted cautiously, considering the potential influence of reverse causality.